Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00051727 · ClinicalTrials.gov registry record · Phase 2

Prevention of School Dropout for Mexican American Adolescents

A Phase 2 study of Depression and Conduct Disorder, sponsored by Arizona State University.

Completed
Registry status
Phase 2
Development phase
480
Enrollment target
1
Study location

NCT00051727 is a Phase 2 study of Depression and Conduct Disorder that has completed, run by Arizona State University. The registered enrollment target is 480 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00051727, a Phase 2 study of Depression and Conduct Disorder, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
Phase 2
Development phase
480 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the efficacy of a family-based psychosocial intervention to prevent school disengagement and reduce the incidence of depression, conduct disorders, and school dropout for Mexican American adolescents.

Interventions

  • BEHAVIORAL Bridges to High School Project

Study Locations (1)

Arizona

  • Prevention Research Center, Arizona State University - Tempe

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 2002-10
Phase Phase 2

Sponsor

Arizona State University

187 total trials

What the Registry Record Tells You About NCT00051727

The ClinicalTrials.gov registry entry for NCT00051727 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (39% lower). The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Bridges to High School Project is the first listed.

NCT00051727 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT00051727 about?

NCT00051727 is a clinical study titled "Prevention of School Dropout for Mexican American Adolescents". The purpose of this study is to test the efficacy of a family-based psychosocial intervention to prevent school disengagement and reduce the incidence of depression, conduct disorders, and school dropout for Mexican American adolescents.

What is the current status of trial NCT00051727?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 480 participants. The study started on 2002-10.

What conditions does trial NCT00051727 study?

This clinical trial studies the following conditions: Depression, Conduct Disorder.

What interventions are being tested in trial NCT00051727?

The interventions under investigation include: Bridges to High School Project (BEHAVIORAL).

Who is sponsoring clinical trial NCT00051727?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00051727 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.